News & Analysis on Clinical Trial Services & Contract Research And Development
A survey of eleven production plants of major drugmakers has revealed considerable variation in capacity utilisation, with the top performers being those who embrace automation and spend little on non-core activities.
Buoyed by lucrative biodefense contracts, Emergent BioSolutions has showcased a new large-scale vaccine production facility in Michigan which it will use to make Biothrax, the only vaccine approved in the US for the prevention of anthrax infection.
Generex has registered a new patent in the US that covers broad claims for the delivery of macromolecules via the buccal cavity of the mouth, further safeguarding its RapidMist drug delivery technology which it uses to spray insulin into the mouth.
As it continues to expand, Decision News Media is currently seeking two new journalists to join its Pharmaceutical & Science News Group in Central London.
Instrumentation provider ABgene has launched the first automated device for the opening and closing of screw caps on sample tubes that it claims is three times faster than the manual method.
Global drug development spending will top $105bn (€81.5bn) by 2010 and 40 per cent of this business is expected to be dished out in outsourcing contracts - with contract research organisations (CROs) emerging triumphant.